Page last updated: 2024-12-07

n-hexadecyl-n,n-dimethyl-3-ammonio-1-propanesulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID92176
CHEMBL ID1213509
SCHEMBL ID62048
MeSH IDM0249349

Synonyms (47)

Synonym
CHEMBL1213509
nsc-628322
nsc628322
zwittergent 3-16
3-(hexadecyl(dimethyl)-.lambda.~5~-azanyl)-1-propanesulfonic acid
hexadecyl-dimethyl-(3-sulfopropyl)ammonium
H1283
hexadecyldimethyl(3-sulfopropyl)ammonium hydroxide inner salt
2281-11-0
3-(hexadecyldimethylammonio)propane-1-sulfonate
palmityl sulfobetaine
3-[dimethyl(palmityl)ammonio]propane-1-sulfonate
palmityldimethyl(3-sulfopropyl)ammonium hydroxide inner salt
FT-0653481
3-[hexadecyl(dimethyl)azaniumyl]propane-1-sulfonate
3-(n,n-dimethylpalmitylammonio)propanesulfonate
A816371
einecs 218-918-7
sb16
hexadecyldimethyl(3-sulphonatopropyl)ammonium
haf4am3vbf ,
unii-haf4am3vbf
n-hexadecyl-n,n-dimethyl-3-ammonio-1-propanesulfonate
1-hexadecanaminium, n,n-dimethyl-n-(3-sulfopropyl)-, hydroxide, inner salt
AKOS015897497
TUBRCQBRKJXJEA-UHFFFAOYSA-N
SCHEMBL62048
hexadecyldimethyl(3-sulfopropyl)ammonium hydroxide inner salt [for biochemical research]
c21h45no3s
mfcd00036911
DTXSID70177359
sulfobetaine-16
zwittergent 3-16 detergent
J-014864
DS-6011
3-(hexadecyl-dimethyl-ammonio)propane-1-sulfonate
A51053
1-hexadecanaminium, n,n-dimethyl-n-(3-sulfopropyl)-, inner salt
SB83690
CS-0152217
3-cetyldimethylammonium-1-propanesulfonate
sulfobetaine 16
n-palmityl sulfobetaine
n,n-dimethyl-n-(3-sulfopropyl)-1-hexadecanaminium hydroxide, inner salt
HY-W099575
SY052090
M02489
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID496819Antimicrobial activity against Plasmodium falciparum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's7 (63.64)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.02 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]